Optiscan Imaging partners with University of Minnesota's veterinary faculty to trial cancer imaging technology on pets.

Optiscan Imaging partners with University of Minnesota's veterinary faculty to trial cancer imaging technology on pets, aiming to replace traditional pathology methods. The collaboration uses Optiscan's digital imaging system and a contrast dye, fluorescein. If successful, it could create new standards in animal care and tap the vast US market of domesticated pets diagnosed with cancer annually.

August 19, 2024
3 Articles

Further Reading